The retreatment of carboplatin via high-dose intraperitoneal chemotherapy in patients with a history of a hypersensitivity reaction.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 24184183.
- Also identified by DOI 10.1016/j.ajog.2013.10.883.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A hypersensitivity reaction attributed to platinum-based chemotherapy is a relatively common occurrence. Hyperthermic intraperitoneal chemotherapy potentially facilitates the safe retreatment of platinum therapy following this complication. We describe 3 ovarian cancer patients who were successfully retreated with carboplatin via hyperthermic intraperitoneal chemotherapy following hypersensitivity reaction.
Medical subject headings
- Antineoplastic Agents
- Carboplatin
- Neoplasm Recurrence, Local
- Ovarian Neoplasms